focus -WSS

focus

author：Wikipedia 2025-09-06 03:32:20 - browse：8

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Virginia high school admissions case could be legal follow
Next article： CVS, Rite Aid closures threaten to worsen pharmacy deserts

explore

hotspot

WSS

Ventyx halts psoriasis drug development after lackluster trial results

Friends ask where James Watson's attitudes about race came from

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Today's health inequities arise from racist U.S. history, say experts

A letter from the executive editor: STAT UnitedHealth investigation

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Wikipedia

focus

hotspot

Cancer drug shortages should be causing more outrage

Methadone doses haven’t kept up in the age of fentanyl

In Memoriam: Notable people who died in 2023

Carbon Health diabetes program, a test of data

At least 13 dead in Texas as scorching temps continue

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Healthy food access boosts outcomes in two studies

explore

NIH trials fail to test meaningful long Covid therapies, experts say

Carbon Health diabetes program, a test of data

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Ohio still needs to do more to protect the right to abortion

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

focus

explore

hotspot

hotspot